Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for USB and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for USB and 80,000+ other tickers.
See exactly how USB's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for USB and 80,000+ other tickers.
U.S. Bancorp (USB) functions as a broad-based financial services holding company, delivering a comprehensive spectrum of banking and financial solutions throughout the United States. Its diverse customer base includes individual consumers, various businesses, institutional organizations, governmental bodies, and other financial entities. The company organizes its operations across key segments: Corporate and Commercial Banking, Consumer and Business Banking, Wealth Management and Investment Services, Payment Services, and Treasury and Corporate Support. Its offerings encompass fundamental…
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
A proposed federal drug-discount overhaul could quietly funnel billions in new borrowing demand toward the banks already holding hospital credit lines, and the lenders best positioned to profit may surprise you.
Moving up the dividend yield ladder from a chipmaker near 2% to a package carrier above 6% sounds like a straightforward trade, but each step strips away something you probably assumed you were keeping.
U.S. Bancorp delivered solid third-quarter results, with net interest income up 5.6% and diluted EPS increasing 9.8% year over year. Management expects continued growth, supported by higher fee revenue, capital markets, and the BTIG acquisition. Credit quality remains manageable, but rising credit-loss provisions and broader economic vulnerabilities warrant caution.
NEW YORK--(BUSINESS WIRE)--BTIG, a U.S. Bancorp company, announced today that Bhavesh Lodaya has joined the firm as a Director and Chemicals Analyst. “We see chemicals as an important growth area for our research franchise, and I am excited to welcome Bhavesh as the analyst who will help establish our coverage in this sector,” said Ryan Serwin, CFA, Director of Research at U.S. Bancorp | BTIG. “His industry knowledge, investment perspective, and client focus will be instrumental as we expand ou.